 This study found that next-generation sequencing, NGS, can be used to detect tumor-specific genomic alterations in patients with advanced cancer. It also showed that the application of NGS is feasible in an academic setting and increases the detection of actionable alterations and initiation of match-targeted treatments. This article was authored by Lauren Tuen, Evelyn Roetz, Peter Dahore, and others.